Does Dexmedetomidine as a Neuraxial Adjuvant Facilitate Better Anesthesia and Analgesia? A Systematic Review and Meta-Analysis

Abstract

BackgroundNeuraxial application of dexmedetomidine (DEX) as adjuvant analgesic has been invetigated in some randomized controlled trials (RCTs) but not been approved because of the inconsistency of efficacy and safety in these RCTs. We performed this meta-analysis to access the efficacy and safety of neuraxial DEX as local anaesthetic (LA) adjuvant.MethodsWe searched PubMed, PsycINFO, Scopus, EMBASE, and CENTRAL databases from inception to June 2013 for RCTs that investigated the analgesia efficacy and safety for neuraxial application DEX as LA adjuvant. Effects were summarized using standardized mean differences (SMDs), weighed mean differences (WMDs) or odds ratio (OR) with suitable effect model. The primary outcomes were postoperative pain intensity and analgesic duration, bradycardia and hypotension.ResultsSixteen RCTs involving 1092 participants were included. Neuraxial DEX significantly decreased postoperative pain intensity (SMD, −1.29; 95% confidence interval (CI), −1.70 to −0.89; P<0.00001), prolonged analgesic duration (WMD, 6.93 hours; 95% CI, 5.23 to 8.62; P<0.00001) and increased the risk of bradycardia (OR, 2.68; 95% CI, 1.18 to 6.10; P = 0.02). No evidence showed that neuraxial DEX increased the risk of other adverse events, such as hypotension (OR, 1.54; 95% CI, 0.83 to 2.85; P = 0.17). Additionally, neuraxial DEX was associated with beneficial alterations in postoperative sedation scores and number of analgesic requirements, sensory and motor block characteristics, and intro-operative hemodynamics.ConclusionNeuraxial DEX is a favorable LA adjuvant with better and longer analgesia. The greatest concern is bradycardia. Further large sample trials with strict design and focusing on long-term outcomes are needed.

Efficacy of dexmedetomidine on postoperative shivering: a meta-analysis of clinical trials

“…Dexmedetomidine is a potent and highly selective a 2 -adrenoceptor agonist with sympatholytic, sedative, amnestic, 6 and analgesic 7 properties. Clinical researchers have already studied the administration of dexmedetomidine to prevent shivering.…”

Total knee replacement: a randomized study of clonidine and dexmedetomidine used for epidural postoperative analgesia

“…Neuraxial dexmedetomidine was associated with good sedation scores and lower analgesic requirements and stable into-operative hemodynamics. 22 Crews et al found in their study that the use of continuous levobupoivacaine in addition to morphine via a thoracic epidural catheter produced an excellent segmental sensory block and analgesia. 23 All the above studies showed that dexmedetomidine was a better adjuvant to levobupivacaine in epidural anaesthesia.…”

A Study of Clonidine and Dexmedetomidine as Adjuvant to Epidural Levobupivacaine for Post Operative Analgesia in Infraumbilical Surgeries

“…Neuraxial dexmedetomidine was associated with good sedation scores and lower analgesic requirements and stable into-operative hemodynamics. [22] Crews et al found in their study that the use of continuous levobupoivacaine in addition to morphine via a thoracic epidural catheter produced a excellent segmental sensory block and analgesia. [23] All the above studies showed that dexmedetomidine was a better adjuvant to levobupivacaine in epidural anaesthesia.…”